RCM
ACGN

Rotella Capital Management’s Aceragen Inc ACGN Stock Holding History

Rotella Capital Management’s Portfolio ACGN Stock Details ACGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-131
Closed -$66K – 685
2015
Q2 		$66K Buy
+131
New +$60.1K 0.05% 347

Other funds holding ACGN

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Rotella Capital Management's ACGN Position: Q3 2015 in Review

Rotella Capital Management sold out of Aceragen Inc (ACGN) in Q3 2015, closing a stake of 131 shares — an estimated $66K sold.

Rotella Capital Management first reported a position in ACGN in Q2 2015 and held it in 1 quarter. The position peaked at $66K in Q2 2015. 84 funds tracked by Wall St. Rank hold ACGN as of Q3 2015.

  • Rotella Capital Management reported no remaining Aceragen Inc position as of Q3 2015 after selling out during the quarter.
  • Rotella Capital Management sold 131 Aceragen Inc shares in Q3 2015, an estimated $66K.
  • Rotella Capital Management first reported a position in Aceragen Inc in Q2 2015 and held it in 1 quarter.
  • Rotella Capital Management's Aceragen Inc position peaked at $66K in Q2 2015.
  • 84 funds tracked by Wall St. Rank held Aceragen Inc as of Q3 2015.

Based on Rotella Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.